Researchers in Russia have developed a novel chemical method that could significantly enhance the effectiveness of anti-cancer medicines, offering new momentum to oncology drug development.

The breakthrough, achieved by scientists at Lobachevsky State University of Nizhny Novgorod, focuses on reinforcing the active ingredients of anti-tumour drugs to improve how they interact with and suppress cancer cells. The new technique involves incorporating multiple aminomethyl groups into biologically active molecules. These chemical groups act as pharmacophore elements—key fragments that help determine how effectively a drug engages with its target.

According to the research team, this approach can be applied directly to existing pharmaceutical substances, potentially allowing widely used or approved cancer drugs to be upgraded without needing to develop entirely new compounds. That versatility opens up opportunities to enhance established therapies and accelerate innovation in drug design.

Laboratory results suggest the synthesis process is highly efficient, producing reinforced compounds with nearly 90 per cent yield and over 95 per cent purity, attributes favourable for continued research and possible industrial application in pharmaceutical development.

Beyond strengthening current anti-cancer drugs, the method is also being used to create entirely new biologically active substances, including complex nitrogen-containing heterocycles thought to have therapeutic potential.

The researchers believe this strategy could contribute to the creation of more effective and targeted cancer treatments in the coming years, potentially improving outcomes in oncology by amplifying the impact of existing medicines and expediting the discovery of new ones.